Epizyme Stock News

The company, which invests in royalties on approved and late-stage biopharmaceutical products, filed for the biggest IPO of the year thus far. The news follows biotech's biggest IPO of 2020, China-bas

Epizyme (EPZM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The

Despite the FDA tied up with COVID-19-related activities, May turned out to be a positive month for biopharma companies from the perspective of drug approvals. Three new molecular...

Bryce Jones has been hailed as "a fun loving, energetic man who had a real passion for life

The

Q1 2020 Epizyme Inc Earnings Call

A Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) (“Takeda”) anunciou hoje que a empresa apresentará os dados de seu pipeline de oncologia

Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) („Takeda“) gab heute bekannt, dass das Unternehmen Daten aus seiner wachsenden Onkologiepip

Epizyme (EPZM) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) (“Takeda”) today announced that the company will present data from its expanding oncology p

Epizyme to Present Data from Tazemetostat Clinical Program during the 2020 ASCO Virtual Scientific Program

CASI is focused on developing and commercialising drugs for the Chinese market most notably within the field of hematology/oncology using an innovative in-licen